Ethane-1,1,2,2-d4-sulfonic acid, 2-[[(3α,5β,7β)-3,7-dihydroxy-24-oxocholan-24-yl]amino]-
Ethane-1,1,2,2-d4-sulfonic acid, 2-[[(3α,5β,7β)-3,7-dihydroxy-24-oxocholan-24-yl]amino]- Basic information
- Product Name:
- Ethane-1,1,2,2-d4-sulfonic acid, 2-[[(3α,5β,7β)-3,7-dihydroxy-24-oxocholan-24-yl]amino]-
- Synonyms:
-
- Ethane-1,1,2,2-d4-sulfonic acid, 2-[[(3α,5β,7β)-3,7-dihydroxy-24-oxocholan-24-yl]amino]-
- CAS:
- 2573035-17-1
- MF:
- C26H45NO6S
- MW:
- 499.71
- Mol File:
- 2573035-17-1.mol
Ethane-1,1,2,2-d4-sulfonic acid, 2-[[(3α,5β,7β)-3,7-dihydroxy-24-oxocholan-24-yl]amino]- Chemical Properties
- solubility
- DMSO: Soluble
Ethanol: Soluble
Ethane-1,1,2,2-d4-sulfonic acid, 2-[[(3α,5β,7β)-3,7-dihydroxy-24-oxocholan-24-yl]amino]- Usage And Synthesis
Uses
Tauroursodeoxycholate-d4-1 is the deuterium labeled Tauroursodeoxycholate. Tauroursodeoxycholate (Tauroursodeoxycholic acid) is an endoplasmic reticulum (ER) stress inhibitor. Tauroursodeoxycholate significantly reduces expression of apoptosis molecules, such as caspase-3 and caspase-12. Tauroursodeoxycholate also inhibits ERK.
References
[1] Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. DOI:10.1177/1060028018797110
[2] Kim SY, et al. Tauroursodeoxycholate (TUDCA) inhibits neointimal hyperplasia by suppression of ERK viaPKCα-mediated MKP-1 induction. Cardiovasc Res. 2011 Nov 1;92(2):307-16. DOI:10.1093/cvr/cvr219
[3] Qin Y, et al. Tauroursodeoxycholic Acid Attenuates Angiotensin II Induced Abdominal Aortic Aneurysm Formation in Apolipoprotein E-deficient Mice by Inhibiting Endoplasmic Reticulum Stress. Eur J Vasc Endovasc Surg. 2017 Mar;53(3):337-345. DOI:10.1016/j.ejvs.2016.10.026
[4] BEUERS U. Effects of bile acids on hepatocellular signaling and secretion.[J]. Yale Journal of Biology and Medicine, 1997, 70 4: 341-346.
[5] JEFFREY H BOATRIGHT. Bile acids in treatment of ocular disease.[J]. Journal of ocular biology, diseases, and informatics, 2009, 2 3: 149-159. DOI: 10.1007/s12177-009-9030-x
[6] SHEILA VANG. The Unexpected Uses of Urso- and Tauroursodeoxycholic Acid in the Treatment of Non-liver Diseases.[J]. Global Advances in Health and Medicine, 2014, 3 3: 58-69. DOI: 10.7453/gahmj.2014.017
Ethane-1,1,2,2-d4-sulfonic acid, 2-[[(3α,5β,7β)-3,7-dihydroxy-24-oxocholan-24-yl]amino]-Supplier
- Tel
- 028-83243028 19136088901
- sinostandards@163.com
- Tel
- 17717235263
- cindy.yang@lgcgroup.com
- Tel
- 02151600108 13062666369
- info@isotopechem.com
- Tel
- 021-65675885 18964387627
- customer_service@efebio.com
- Tel
- 800-364-9897
- sales@caymanchem.com
Ethane-1,1,2,2-d4-sulfonic acid, 2-[[(3α,5β,7β)-3,7-dihydroxy-24-oxocholan-24-yl]amino]-(2573035-17-1)Related Product Information
- Tauro-d4-lithocholic Acid Sodium Salt 6042-32-6 unlabelled
- Tauro-d4-deoxycholic Acid Sodium Salt 1180-95-6 unlabelled
- Tauro-d4-chenodeoxycholic Acid Sodium Salt 6009-98-9 unlabelled
- Tauro-d4-cholic Acid Sodium Salt 145-42-6 unlabelled
- Taurodeoxycholic Acid-[d4] Sodium Salt
- Tauroursodeoxycholic Acid-d4
- Taurolithocholic-2,2,4,4-D4 Acid
- Taurodeoxycholic-d4 Acid
- BHTRKEVKTKCXOH-GLYOETPHSA-N